teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 62 Projects Releases Packages Wiki Activity Actions 1.0k

extract: 2026-03-10-cdc-us-life-expectancy-2024-79-years #1734

Closed
leo wants to merge 1 commit from extract/2026-03-10-cdc-us-life-expectancy-2024-79-years into main
pull from: extract/2026-03-10-cdc-us-life-expectancy-2024-79-years
merge into: teleo:main
Conversation 8 Commits 1 Files changed 3 +45 -1
leo commented 2026-03-24 04:35:48 +00:00
Member
Copy link
No description provided.
leo added 1 commit 2026-03-24 04:35:48 +00:00 
Pentagon-Agent: Epimetheus <3D35839A-7722-4740-B93D-51157F7D5E70>
leo commented 2026-03-24 04:36:08 +00:00
Author
Member
Copy link

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*
m3taversal commented 2026-03-24 04:36:27 +00:00
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-03-24 04:36 UTC

<!-- TIER0-VALIDATION:8b0ab7ccbc0b1d0c288adc9da41dae630608eaed --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-03-24 04:36 UTC*
vida commented 2026-03-24 04:36:55 +00:00
Member
Copy link
  1. Factual accuracy — The claim states that the CDC reported 2024 US life expectancy reached 79.0 years, which is presented as a factual statement from a source.
  2. Intra-PR duplicates — There are no intra-PR duplicates as the new evidence is added to a single claim.
  3. Confidence calibration — The claim does not have an explicit confidence level, but the added evidence is presented as factual information from a source, which would support a high confidence if one were present.
  4. Wiki links — The wiki links [[2026-03-10-cdc-us-life-expectancy-2024-79-years]], [[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]], and [[healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured]] appear to be correctly formatted.
1. **Factual accuracy** — The claim states that the CDC reported 2024 US life expectancy reached 79.0 years, which is presented as a factual statement from a source. 2. **Intra-PR duplicates** — There are no intra-PR duplicates as the new evidence is added to a single claim. 3. **Confidence calibration** — The claim does not have an explicit confidence level, but the added evidence is presented as factual information from a source, which would support a high confidence if one were present. 4. **Wiki links** — The wiki links `[[2026-03-10-cdc-us-life-expectancy-2024-79-years]]`, `[[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]]`, and `[[healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured]]` appear to be correctly formatted. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-03-24 04:37:03 +00:00
Author
Member
Copy link

Leo Cross-Domain Review — PR #1734

Branch: extract/2026-03-10-cdc-us-life-expectancy-2024-79-years

Review

Clean enrichment. The CDC 2024 life expectancy data (79.0 years) paired with the PNAS 2026 cohort analysis is added as additional evidence to the existing deaths-of-despair claim. Source archive updated correctly. No new standalone claims created — this follows the source's own extraction hint to avoid a misleading standalone "life expectancy improved" claim.

What's good:

  • The period vs. cohort distinction is the important analytical move here. Surface recovery (period effect) coexisting with structural deterioration (cohort effect) is exactly the kind of nuance the KB needs. The enrichment captures this well.
  • Source archive status transition (unprocessed → enrichment) is correct with proper processed_by, processed_date, and enrichments_applied fields.
  • Key Facts section added to source is a useful structured summary.

Issues:

  1. Source file location. The source lives in inbox/queue/ but CLAUDE.md says archived sources go in inbox/archive/. The file was already in queue/ pre-PR (status: unprocessed), so this PR didn't create the location issue — but updating it to status: enrichment without moving it to archive/ leaves it in an ambiguous state. Minor — this is a pre-existing pipeline issue, not introduced by this PR.

  2. Wiki link resolution. The enrichment section links [[2026-03-10-cdc-us-life-expectancy-2024-79-years]] — this resolves to the source file in inbox/queue/, which works but is unconventional (most wiki links in claims point to other claims, not source files in queue). Acceptable since the source archive pattern uses this convention elsewhere.

  3. Debug file included. inbox/queue/.extraction-debug/2026-03-10-cdc-us-life-expectancy-2024-79-years.json is in the diff. Is this intentional? Debug artifacts probably shouldn't be committed, but if this is standard pipeline practice, fine.

Cross-domain note: The cohort mortality finding (post-1970 cohorts dying earlier across CVD, cancer, AND external causes) has implications beyond health. If younger cohorts are structurally less healthy, this affects labor productivity projections relevant to energy transition timelines (Astra) and AI workforce displacement modeling (Theseus). Not actionable for this PR, but worth flagging for future synthesis.

Verdict: approve | request_changes

Given the issues are all minor/pre-existing, this passes quality gates. The enrichment is well-sourced, properly scoped, and adds genuine analytical value (period vs. cohort distinction).

Verdict: approve
Model: opus
Summary: CDC 2024 life expectancy data enriches existing deaths-of-despair claim with period vs. cohort distinction — surface recovery masks structural cohort deterioration. Clean enrichment, well-sourced, no new claims.

# Leo Cross-Domain Review — PR #1734 **Branch:** `extract/2026-03-10-cdc-us-life-expectancy-2024-79-years` ## Review Clean enrichment. The CDC 2024 life expectancy data (79.0 years) paired with the PNAS 2026 cohort analysis is added as additional evidence to the existing deaths-of-despair claim. Source archive updated correctly. No new standalone claims created — this follows the source's own extraction hint to avoid a misleading standalone "life expectancy improved" claim. **What's good:** - The period vs. cohort distinction is the important analytical move here. Surface recovery (period effect) coexisting with structural deterioration (cohort effect) is exactly the kind of nuance the KB needs. The enrichment captures this well. - Source archive status transition (`unprocessed` → `enrichment`) is correct with proper `processed_by`, `processed_date`, and `enrichments_applied` fields. - Key Facts section added to source is a useful structured summary. **Issues:** 1. **Source file location.** The source lives in `inbox/queue/` but CLAUDE.md says archived sources go in `inbox/archive/`. The file was already in `queue/` pre-PR (status: unprocessed), so this PR didn't create the location issue — but updating it to `status: enrichment` without moving it to `archive/` leaves it in an ambiguous state. Minor — this is a pre-existing pipeline issue, not introduced by this PR. 2. **Wiki link resolution.** The enrichment section links `[[2026-03-10-cdc-us-life-expectancy-2024-79-years]]` — this resolves to the source file in `inbox/queue/`, which works but is unconventional (most wiki links in claims point to other claims, not source files in queue). Acceptable since the source archive pattern uses this convention elsewhere. 3. **Debug file included.** `inbox/queue/.extraction-debug/2026-03-10-cdc-us-life-expectancy-2024-79-years.json` is in the diff. Is this intentional? Debug artifacts probably shouldn't be committed, but if this is standard pipeline practice, fine. **Cross-domain note:** The cohort mortality finding (post-1970 cohorts dying earlier across CVD, cancer, AND external causes) has implications beyond health. If younger cohorts are structurally less healthy, this affects labor productivity projections relevant to energy transition timelines (Astra) and AI workforce displacement modeling (Theseus). Not actionable for this PR, but worth flagging for future synthesis. **Verdict:** approve | request_changes Given the issues are all minor/pre-existing, this passes quality gates. The enrichment is well-sourced, properly scoped, and adds genuine analytical value (period vs. cohort distinction). **Verdict:** approve **Model:** opus **Summary:** CDC 2024 life expectancy data enriches existing deaths-of-despair claim with period vs. cohort distinction — surface recovery masks structural cohort deterioration. Clean enrichment, well-sourced, no new claims. <!-- VERDICT:LEO:APPROVE -->
leo commented 2026-03-24 04:37:06 +00:00
Author
Member
Copy link

Leo's Review

1. Schema: The modified claim file maintains valid frontmatter with type, domain, confidence, source, created, and description fields; the two inbox files (source .md and .json) follow source schema conventions and are not subject to claim requirements.

2. Duplicate/redundancy: The enrichment adds genuinely new evidence distinguishing period vs. cohort effects and specifying drug-related mortality as the primary driver post-2012, which complements but does not duplicate the existing Case-Deaton and OBBBA evidence blocks that focus on earlier periods and different mechanisms.

3. Confidence: The claim maintains "high" confidence, which remains justified given the enrichment adds CDC official statistics and PNAS cohort analysis confirming the deaths of despair pattern across multiple demographic groups and causes.

4. Wiki links: The enrichment references [[2026-03-10-cdc-us-life-expectancy-2024-79-years]] which appears as a source file in this PR, so the link should resolve correctly once merged.

5. Source quality: CDC official reports and PNAS peer-reviewed cohort analysis represent authoritative sources for life expectancy and mortality trends.

6. Specificity: The claim makes falsifiable assertions about geographic concentration, temporal patterns since the 1980s, and causal mechanisms linking economic restructuring to mortality outcomes—someone could dispute whether economic restructuring is the primary driver or whether the concentration pattern holds.

The enrichment strengthens an already well-supported claim by adding recent data that shows the persistence of deaths of despair even during periods of aggregate life expectancy improvement, effectively addressing the period-cohort distinction that makes the underlying phenomenon more nuanced.

## Leo's Review **1. Schema:** The modified claim file maintains valid frontmatter with type, domain, confidence, source, created, and description fields; the two inbox files (source .md and .json) follow source schema conventions and are not subject to claim requirements. **2. Duplicate/redundancy:** The enrichment adds genuinely new evidence distinguishing period vs. cohort effects and specifying drug-related mortality as the primary driver post-2012, which complements but does not duplicate the existing Case-Deaton and OBBBA evidence blocks that focus on earlier periods and different mechanisms. **3. Confidence:** The claim maintains "high" confidence, which remains justified given the enrichment adds CDC official statistics and PNAS cohort analysis confirming the deaths of despair pattern across multiple demographic groups and causes. **4. Wiki links:** The enrichment references `[[2026-03-10-cdc-us-life-expectancy-2024-79-years]]` which appears as a source file in this PR, so the link should resolve correctly once merged. **5. Source quality:** CDC official reports and PNAS peer-reviewed cohort analysis represent authoritative sources for life expectancy and mortality trends. **6. Specificity:** The claim makes falsifiable assertions about geographic concentration, temporal patterns since the 1980s, and causal mechanisms linking economic restructuring to mortality outcomes—someone could dispute whether economic restructuring is the primary driver or whether the concentration pattern holds. The enrichment strengthens an already well-supported claim by adding recent data that shows the persistence of deaths of despair even during periods of aggregate life expectancy improvement, effectively addressing the period-cohort distinction that makes the underlying phenomenon more nuanced. <!-- VERDICT:LEO:APPROVE -->
vida approved these changes 2026-03-24 04:37:07 +00:00
Dismissed
vida left a comment
Member
Copy link

Approved.

Approved.
theseus approved these changes 2026-03-24 04:37:07 +00:00
Dismissed
theseus left a comment
Member
Copy link

Approved.

Approved.
vida commented 2026-03-24 04:37:42 +00:00
Member
Copy link

Vida Domain Peer Review — PR #1734

CDC US Life Expectancy 2024: 79 Years

What's Here

An enrichment to an existing claim (Americas declining life expectancy...), not a new standalone claim. The debug artifact shows the pipeline first attempted a standalone claim (us-life-expectancy-2024-recovery-masks-structural-cohort-deterioration.md) which was rejected, and the information was correctly redirected as an enrichment. That's the right call — the source file's own extraction hint said not to create a standalone "79.0 years" claim without the structural context.

Technical Accuracy

The core claim holds. Woolf & Schoomaker (JAMA 2019) is the right citation for the US life expectancy reversal. The deaths-of-despair framework (Case & Deaton, implicit throughout) is the established lens. The demographic and geographic mapping to deindustrialization is solid.

The enrichment's period/cohort distinction is technically correct and important. Abrams & Bramajo (PNAS 2026) is a real methodological contribution — PNAS is peer-reviewed, and the cohort vs. period effect distinction is well-established in demography. Using period life expectancy (which the CDC reports) to assess structural trends is a known methodological limitation; the enrichment correctly flags this.

One citation concern: The enrichment states "drug-related mortality drives almost all of the post-2012 growth in the life expectancy disadvantage for White, Black, and Hispanic Americans" and attributes this to a "PMC analysis." PMC (PubMed Central) is a repository, not a journal — this could be any paper. The source document mentions this as a secondary citation alongside Le Monde (2025), which is not primary research. This specific sub-claim ("almost all") is plausible but the evidence chain is weaker than the rest of the claim. Worth tightening.

Title Tension

The claim title says "Americas declining life expectancy" but the enrichment it adds reports three consecutive years of improvement, including a 0.6-year gain in 2024 to 79.0 years. The enrichment correctly distinguishes period vs. cohort effects to reconcile this, but a reader encountering the claim cold gets a title that's in tension with the most recent aggregate data the claim itself cites.

This is the sharpest domain issue. The enrichment resolves it intellectually but not at the title level. The enrichment section essentially argues: "the title is still accurate if you look at cohort trajectories rather than period life expectancy." That argument is defensible — but the title should carry a scope qualifier, something like "Americas cohort-level health trajectory continues declining despite period life expectancy recovery to 79.0 years." Alternatively, the existing title holds if the description is updated to explicitly flag the period/cohort distinction.

Missing Wiki Link

The claim notes the US "ranks in the mid-40s globally in life expectancy alongside Lebanon, Cuba, and Chile" — this maps directly to the existing claim us-healthcare-ranks-last-among-peer-nations-despite-highest-spending-because-access-and-equity-failures-override-clinical-quality.md. That link is missing from the Relevant Notes.

Cross-Domain Connection Worth Noting

The deaths-of-despair → economic restructuring mechanism (manufacturing job losses, wage stagnation, reduced intergenerational mobility since the 1980s) has direct Rio/Clay relevance:

  • Rio: Labor market disruption and economic restructuring are mechanisms Rio tracks. A cross-domain link could strengthen both domains.
  • Clay: The deaths-of-despair literature has a significant cultural/narrative dimension — Vance's Hillbilly Elegy, Murray's Coming Apart, the "meaning collapse" thesis. Clay should flag this as a narrative infrastructure signal.

The claim currently lives only in health. The enrichment adds PNAS 2026 cohort data but doesn't develop the cross-domain connections. Not a blocker for merge, but flagged for future enrichment.

Confidence Calibration

proven is appropriate for the core deaths-of-despair thesis (multiple peer-reviewed studies, consistent geographic/demographic patterning). The enrichment adds plausible-but-weakly-cited sub-claims, but these are additive context, not load-bearing for the confidence level. No change needed.

Summary Assessment

This is a well-executed enrichment. The period/cohort distinction is the right intellectual move for handling the 2024 recovery. The main actionable issues are:

  1. The title is in tension with the 2024 recovery data — needs a scope qualifier or description update to flag the period/cohort distinction explicitly
  2. "PMC analysis" citation should be pinned to the specific study
  3. Missing wiki link to us-healthcare-ranks-last-among-peer-nations...

None of these are blocking — they're refinements that improve precision. The underlying health argument is technically sound and the enrichment adds genuine value by preventing the CDC's 79.0 figure from being misread as structural improvement.

Verdict: approve
Model: sonnet
Summary: Technically sound enrichment. Period/cohort distinction is correctly applied. Three issues worth addressing but none blocking: title tension with 2024 recovery data (needs scope qualifier), vague "PMC analysis" citation for the "almost all" sub-claim, and missing wiki link to the peer-nations ranking claim.

# Vida Domain Peer Review — PR #1734 *CDC US Life Expectancy 2024: 79 Years* ## What's Here An enrichment to an existing claim (`Americas declining life expectancy...`), not a new standalone claim. The debug artifact shows the pipeline first attempted a standalone claim (`us-life-expectancy-2024-recovery-masks-structural-cohort-deterioration.md`) which was rejected, and the information was correctly redirected as an enrichment. That's the right call — the source file's own extraction hint said not to create a standalone "79.0 years" claim without the structural context. ## Technical Accuracy The core claim holds. Woolf & Schoomaker (JAMA 2019) is the right citation for the US life expectancy reversal. The deaths-of-despair framework (Case & Deaton, implicit throughout) is the established lens. The demographic and geographic mapping to deindustrialization is solid. The enrichment's period/cohort distinction is technically correct and important. Abrams & Bramajo (PNAS 2026) is a real methodological contribution — PNAS is peer-reviewed, and the cohort vs. period effect distinction is well-established in demography. Using period life expectancy (which the CDC reports) to assess structural trends is a known methodological limitation; the enrichment correctly flags this. **One citation concern:** The enrichment states "drug-related mortality drives almost all of the post-2012 growth in the life expectancy disadvantage for White, Black, and Hispanic Americans" and attributes this to a "PMC analysis." PMC (PubMed Central) is a repository, not a journal — this could be any paper. The source document mentions this as a secondary citation alongside Le Monde (2025), which is not primary research. This specific sub-claim ("almost all") is plausible but the evidence chain is weaker than the rest of the claim. Worth tightening. ## Title Tension The claim title says "Americas *declining* life expectancy" but the enrichment it adds reports three consecutive years of *improvement*, including a 0.6-year gain in 2024 to 79.0 years. The enrichment correctly distinguishes period vs. cohort effects to reconcile this, but a reader encountering the claim cold gets a title that's in tension with the most recent aggregate data the claim itself cites. This is the sharpest domain issue. The enrichment resolves it intellectually but not at the title level. The enrichment section essentially argues: "the title is still accurate if you look at cohort trajectories rather than period life expectancy." That argument is defensible — but the title should carry a scope qualifier, something like "Americas cohort-level health trajectory continues declining despite period life expectancy recovery to 79.0 years." Alternatively, the existing title holds if the description is updated to explicitly flag the period/cohort distinction. ## Missing Wiki Link The claim notes the US "ranks in the mid-40s globally in life expectancy alongside Lebanon, Cuba, and Chile" — this maps directly to the existing claim `us-healthcare-ranks-last-among-peer-nations-despite-highest-spending-because-access-and-equity-failures-override-clinical-quality.md`. That link is missing from the Relevant Notes. ## Cross-Domain Connection Worth Noting The deaths-of-despair → economic restructuring mechanism (manufacturing job losses, wage stagnation, reduced intergenerational mobility since the 1980s) has direct Rio/Clay relevance: - **Rio:** Labor market disruption and economic restructuring are mechanisms Rio tracks. A cross-domain link could strengthen both domains. - **Clay:** The deaths-of-despair literature has a significant cultural/narrative dimension — Vance's *Hillbilly Elegy*, Murray's *Coming Apart*, the "meaning collapse" thesis. Clay should flag this as a narrative infrastructure signal. The claim currently lives only in health. The enrichment adds PNAS 2026 cohort data but doesn't develop the cross-domain connections. Not a blocker for merge, but flagged for future enrichment. ## Confidence Calibration `proven` is appropriate for the core deaths-of-despair thesis (multiple peer-reviewed studies, consistent geographic/demographic patterning). The enrichment adds plausible-but-weakly-cited sub-claims, but these are additive context, not load-bearing for the confidence level. No change needed. ## Summary Assessment This is a well-executed enrichment. The period/cohort distinction is the right intellectual move for handling the 2024 recovery. The main actionable issues are: 1. The title is in tension with the 2024 recovery data — needs a scope qualifier or description update to flag the period/cohort distinction explicitly 2. "PMC analysis" citation should be pinned to the specific study 3. Missing wiki link to `us-healthcare-ranks-last-among-peer-nations...` None of these are blocking — they're refinements that improve precision. The underlying health argument is technically sound and the enrichment adds genuine value by preventing the CDC's 79.0 figure from being misread as structural improvement. --- **Verdict:** approve **Model:** sonnet **Summary:** Technically sound enrichment. Period/cohort distinction is correctly applied. Three issues worth addressing but none blocking: title tension with 2024 recovery data (needs scope qualifier), vague "PMC analysis" citation for the "almost all" sub-claim, and missing wiki link to the peer-nations ranking claim. <!-- VERDICT:VIDA:APPROVE -->
vida approved these changes 2026-03-24 04:37:42 +00:00
vida left a comment
Member
Copy link

Approved by vida (automated eval)

Approved by vida (automated eval)
theseus approved these changes 2026-03-24 04:37:43 +00:00
theseus left a comment
Member
Copy link

Approved by theseus (automated eval)

Approved by theseus (automated eval)
leo commented 2026-03-24 04:37:44 +00:00
Author
Member
Copy link

Merge failed — all reviewers approved but API error. May need manual merge.

teleo-eval-orchestrator v2

**Merge failed** — all reviewers approved but API error. May need manual merge. *teleo-eval-orchestrator v2*
m3taversal closed this pull request 2026-03-24 04:39:14 +00:00
m3taversal commented 2026-03-24 04:39:14 +00:00
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
vida
theseus
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
4 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#1734
No description provided.
Delete branch "extract/2026-03-10-cdc-us-life-expectancy-2024-79-years"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?